Briefcase

Discussions on Brain Health and Cognitive Concerns

Launch Date
02/06/2025
Credit Amount
1
Credit Expires
02/06/2026

Faculty

Nathaniel Chin, MD
Moderator
Associate Professor, University of Wisconsin Department of Medicine, Geriatric Division
Medical Director & Clinical Core Co-Leader, Wisconsin Alzheimer's Disease Research Center (ADRC)
Medical Director, Wisconsin Registry for Alzheimer's Prevention (WRAP) Study
Associate Director, Geriatric Memory Program, University of Wisconsin Hospitals and Clinics
Madison, WI
Anna D. Burke, MD
Karsten Solheim Chair for Dementia
Director of Alzheimer’s and Memory Disorders Division
Director of Neuropsychiatry
Professor of Neurology
Department of Neurology
Barrow Neurological Institute
Phoenix, AZ
Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

To improve the quality of care for patients with Alzheimer’s disease (AD), health care professionals (HCPs) are positioned to assess brain health and provide the crucial early diagnosis, especially in diverse, underserved patient populations. HCPs must implement emerging care strategies, including use of validated diagnostic tools to pinpoint patients suitable for therapies that may slow disease progression, while implementing a culturally sensitive approach that includes shared decision-making (SDM).

In the first activity of this CME Outfitters BriefCase series, expert faculty will utilize a patient case format to illustrate utilization of current and emerging screening and diagnostic tools in diverse populations for early detection of AD, as well as integration of culturally sensitive patient and caregiver education strategies to improve SDM on brain health and AD management with patients.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Utilize current and emerging diagnostic tools in diverse populations for detection of AD early in the disease course
  • Integrate culturally sensitive patient and caregiver education strategies to improve SDM on brain health and/or AD management with patients

Financial Support

This activity is supported by an educational grant from Lilly.

Target Audience

Neurologists, geriatricians, geriatric psychiatrists, PCPs, nurse practitioners (NPs), physician associates (PAs), nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours (0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-25-028-H01-P).

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Physician Assistants (AAPA): 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 02/06/2026. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. Relevant financial relationships exist between the following individuals and commercial interests:

Dr. Chin reports the following financial relationships:

Consultant: New Amsterdam Pharma

Stock Shareholder (directly purchased): Abbott Laboratories; AbbVie; Amgen; AstraZeneca; Biogen; CVS; Eli Lilly; Exact Sciences Corp; Gilead; Johnson & Johnson; Medtronic; and Roche Holdings

Dr. Burke reports the following financial relationships:

Advisory Board and Consultant: Eisai and Lilly

Research Support: AbbVie; Alector; Biogen; EIP Pharma; Janssen; Lilly; and Roche

Speakers Bureau: Eisai and Lilly

The following individuals have no financial relationships to disclose:

Rebecca Vargas-Jackson, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Estelle Perera (Planning Committee)
Chelsey Goins, PhD (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

BC-131-020625-11

Discussions on Brain Health and Cognitive Concerns
Event Date: 02/06/2025
Begin